Proxy Results Form 8 K

Item 5.02. Departure of Directors or Certain Officers; Election of Directors: Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On September 6, 2024, Alimera Sciences, Inc. (the "Company") amended the employment agreements (collectively, the "Amendments") of each of Richard S. Eiswirth, Jr., Elliot Maltz, Jason Werner and Todd Wood to provide each such executive a make-whole tax reimbursement payment in respect of any excise taxes incurred by such executive under Section 4999 of the Internal Revenue Code that are triggered as a result of the consummation of the transactions contemplated by the Agreement and Plan of Merger (the "Merger Agreement"), dated as of June 21, 2024, as may be amended from time to time, among the Company, ANI Pharmaceuticals, Inc., a Delaware corporation ("Parent"), and ANIP Merger Sub INC., a Delaware corporation and wholly owned indirect subsidiary of Parent ("Merger Sub").

The foregoing is a summary of the material terms of the Amendments and is qualified in its entirety by reference to the full text of the Amendments, which are filed as Exhibits 10.1, 10.2, 10.3 and 10.4 hereto and incorporated herein by reference.